How low do you need to go? Comparing symptoms of diet induction and mood with outcomes from diets containing differing levels of carbohydrate restriction.
- Conditions
- obesitydiabetescardiovascular diseaseDiet and Nutrition - ObesityMetabolic and Endocrine - DiabetesCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12617000421336
- Lead Sponsor
- AUT University
- Brief Summary
Key findings: • Reduced carbohydrate diets have a positive effect on markers of health • Low-carbohydrate diets were easily adhered to over a 12-week period • There were significant and clinically meaningful improvements in weight, waist-height ratio, HDL-c and TG. • All diets were functionally ketogenic based on the mean level of BOHB achieved per group • A 5% carbohydrate allocation is consistently ketogenic for almost all participants, but a low-carbohydrate intervention of 25% or 15% carbohydrate can be ketogenic for some people. • Symptoms of carbohydrate withdrawal increased concomitant to the magnitude of carbohydrate restriction, but the changes from baseline were small, and there was no significant difference between intervention groups. • Mean reported symptoms differed by less than 2 out of a possible score of 48 (range between groups; 3.00 - 4.95), and there is little clinically meaningful difference in adverse effects of carbohydrate withdrawal between diets differing in carbohydrate restriction. • The ‘keto-flu’ is limited to the symptoms of breath expression of ketone bodies and a minor increase in muscle weakness. • Mood improved significantly from baseline as a result of all dietary interventions but did not differ significantly between groups
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 77
Non-obese, non-diabetic, between the ages of 25 and 49.
BMI <19 or >30, diagnosed metabolic condition such as diabetes, or cardiovascular disease, chronic kidney or liver disease. Pregnancy or breastfeeding. Habitual intake of >40% calories from carbohydrate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in mood from baseline (POMS-SF)[12 weeks];Change in carbohydrate withdrawal questionnaire (Symptoms-Q) from baseline[12 weeks ]
- Secondary Outcome Measures
Name Time Method Change in triglyceride to HDL cholesterol ratio from serum assay[Twelve weeks];Change in HbA1c from serum assay [Twelve weeks];Change in total cholesterol to HDL ratio from serum assay, [twelve weeks];change in body fat percentage - measured by skinfold callipers at baseline and completion[twelve weeks];Change in waist to hip ratio as measured by tape measure at baseline and completion [twelve weeks];Change in serum urate (from serum assay)[twelve weeks];Change in c-reactive protein as measured y serum assay[twelve weeks]